[APACHE II, APACHE III, SOFA scoring systems, platelet counts and mortality in septic and nonseptic patients].
暂无分享,去创建一个
[1] J. Vincent,et al. Platelet function in sepsis , 2004, Critical care medicine.
[2] Corinne Alberti,et al. Calibration and discrimination by daily Logistic Organ Dysfunction scoring comparatively with daily Sequential Organ Failure Assessment scoring for predicting hospital mortality in critically ill patients* , 2002, Critical care medicine.
[3] V. Pettilä,et al. Comparison of multiple organ dysfunction scores in the prediction of hospital mortality in the critically ill* , 2002, Critical care medicine.
[4] C. Koebnick,et al. Thrombocytopenia in patients in the medical intensive care unit: Bleeding prevalence, transfusion requirements, and outcome* , 2002, Critical care medicine.
[5] J. Vincent,et al. Time course of platelet counts in critically ill patients , 2002, Critical care medicine.
[6] B. Afessa,et al. Systemic inflammatory response syndrome, organ failure, and outcome in critically ill obstetric patients treated in an ICU. , 2001, Chest.
[7] M. Nijsten,et al. Blunted rise in platelet count in critically ill patients is associated with worse outcome , 2000, Critical care medicine.
[8] E. Hanisch,et al. [The SOFA score in evaluating septic illnesses. Correlations with the MOD and APACHE II score]. , 2000, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
[9] A. Wilmer,et al. Thrombocytopenia and prognosis in intensive care , 2000, Critical care medicine.
[10] J. Vincent,et al. Scoring systems for assessing organ dysfunction and survival. , 2000, Critical care clinics.
[11] F. Bonnet,et al. Thrombocytopenia in critically ill surgical patients: a case-control study evaluating attributable mortality and transfusion requirements , 1999, Critical care.
[12] C. Sprung,et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study , 1999, Intensive Care Medicine.
[13] A. Flahault,et al. Thrombocytopenia in a surgical ICU. , 1999, Chest.
[14] C. Sprung,et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. , 1998, Critical care medicine.
[15] V. Praloran,et al. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. , 1997, The American journal of medicine.
[16] J. Vincent,et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.
[17] F Doyon,et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. , 1995, JAMA.
[18] R. Baughman,et al. Thrombocytopenia in the intensive care unit. , 1993, Chest.
[19] W. Knaus,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.
[20] W. Knaus,et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. , 1991, Chest.
[21] Michael F. Wilson,et al. Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. , 1990, Critical care medicine.
[22] J. L. Gall,et al. APACHE II--a severity of disease classification system. , 1986, Critical care medicine.
[23] D. E. Lawrence,et al. APACHE—acute physiology and chronic health evaluation: a physiologically based classification system , 1981, Critical care medicine.